We have chosen medical device coatings as the first application of our technology – a proving ground where the platform’s ability to create a better interface with the body matters most. Inspired by naturally occurring biological interactions, these coatings are designed to leverage, rather than disrupt, the body’s normal processes. By creating a more favorable interface between a device and its biological surroundings, the technology aims to enhance device performance while supporting biocompatibility and patient well-being. Our unique approach, validated on a broad range of biomaterials and devices, avoids the need for cytotoxic agents for the control of pathogens, and provides an optimized healing environment.
Ommio Health
Ommio Health has built a proprietary platform and a broad intellectual property portfolio, with the versatility to elevate products across life-science applications. We give partners a foundation to create differentiated, next-generation solutions that work in greater harmony with the body.
Ommio is derived from the Greek word omoiostasia, meaning homeostasis. This concept of balance guides our approach to innovation.
PARTNERSHIP OPPORTUNITIES
Meet the Team
Management
Konstantine Drakonakis, PE
Executive Chairman / Co-Founder
Konstantine is an experienced entrepreneur and investor with 20 years of building high tech therapeutic and advanced material companies.
He is presently the a managing venture partner for Connecticut Innovations, Climate Tech Fund. Konstantine is also a partner with the Pritzker Vlock Family Office, where he was a founding member and director of LaunchCapital’s New Haven CT Office, the firm’s early-stage-focused venture firm. He developed a portfolio of 40 companies, representing over 100 transactions and more than $1 billion in syndication. Konstantine has also been a founder and operator of four tech companies: 6K, Katharos, PlazMod and Ommio Health. He is a board member/director at 6K (where he was the Founding Executive Chairman and former CSO), EpiEP, TearSolutions, and Iridia. Konstantine is also an active member in the university entrepreneurial ecosystem.
READ MORE▼
Carl Christianson, Ph.D.
Chief Operating Officer
Carl is a seasoned entrepreneur, having been a founder, co-founder, and advisor on numerous projects in the AgTech and BioTech sectors over the past decade.
His background as a natural product chemist has driven his interest in these areas. He performed his Ph.D. in Chemistry at Boston College and postdoctoral research at the Max Planck Institute of Colloids and Interfaces, in Berlin Germany. While working in innovative sectors, Carl has spent time at the state and Federal levels, educating and collaborating with lawmakers to effectively understand and craft regulations for new scientific markets. He is dedicated to the craft of building companies and teams to efficiently and effectively tackle complex issues associated with the advancement of human health and safety.
READ MORE▼
George Maynard, Ph.D.
Chief Science Officer
George is a proven leader in the pharmaceutical industry, with 30+ years experience in research and development programs for companies focused on bringing innovative therapeutic candidates to market.
He has served as President and Chief Scientific Officer of ReNetX Bio, VP of Early Development at Neurogen, and as a Project Team Leader at Hoechst Marion Roussel. George is a medicinal chemist with extensive experience in drug discovery, including non-clinical and clinical development work. He has advanced multiple programs from early stage discovery through clinical testing. His creativity and breadth of experience enable Ommio Health to pursue a number of diverse applications with their proprietary platform.
Nick Breault
Vice President of Operations
Nick has demonstrated exceptional leadership in startups, building and leading cross-functional teams to successfully bring cutting-edge medical devices to market.
His extensive knowledge of polymers has been instrumental in driving innovation in advanced manufacturing and medical device development. A passionate entrepreneur and skilled strategist with a firm grasp of regulatory requirements, Nick has orchestrated successful FDA interactions and successfully expedited the approval process and launch of new devices. Combining strong operational skills with business acumen, he established manufacturing facilities for polymer processing and medical device production. Nick's leadership extends to implementation, budgeting, financial reporting, and due diligence activities, ensuring smooth operation and financial health of ventures.
READ MORE▼